eicosapentaenoic acid ethyl ester has been researched along with Cerebral Infarction in 1 studies
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsumata, T | 1 |
Katayama, Y | 1 |
Obo, R | 1 |
Muramatsu, H | 1 |
Ohtori, T | 1 |
Terashi, A | 1 |
1 other study available for eicosapentaenoic acid ethyl ester and Cerebral Infarction
Article | Year |
---|---|
Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model.
Topics: Animals; Autoradiography; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Delayed- | 1999 |